$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

$esta Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000168875719000025 Filed on May 15, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q1
Revenue	$21.68M	$20.78M	$14.82M
YoY Change	58.17%	40.24%	114.1%
Cost Of Revenue	$8.672M	$9.526M	$6.901M
YoY Change	57.9%	38.04%	96.61%
Gross Profit	$13.01M	$11.25M	$7.915M
YoY Change	58.35%	42.16%	132.11%
Gross Profit Margin	60.01%	54.15%	53.42%
Selling, General & Admin	$18.39M	$16.06M	$8.648M
YoY Change	69.86%	85.66%	47.83%
% of Gross Profit	141.36%	142.69%	109.26%
Research & Development	$4.001M	$3.584M	$2.147M
YoY Change	7.99%	66.93%	43.13%
% of Gross Profit	30.75%	31.85%	27.13%
Depreciation & Amortization	$21.00K	$21.00K	$24.00K
YoY Change	-12.5%	-12.5%	-90.4%
% of Gross Profit	0.16%	0.19%	0.3%
Operating Expenses	$22.40M	$19.64M	$10.80M
YoY Change	54.09%	81.94%	46.87%
Operating Profit	-$9.383M	-$8.388M	-$2.880M
YoY Change	48.54%	191.25%	-26.9%
Interest Expense	$2.521M	$2.242M	$2.171M
YoY Change	16.01%	3.27%	-279.42%
% of Operating Profit
Other Income/Expense, Net	$118.0K	-$304.0K	$195.0K
YoY Change	-105.47%	-255.9%	21.88%
Pretax Income	-$9.005M	-$10.74M	-$6.520M
YoY Change	72.91%	64.65%	30.66%
Income Tax	$35.00K	$44.00K	$10.00K
% Of Pretax Income
Net Earnings	-$9.040M	-$10.78M	-$6.530M
YoY Change	68.66%	65.07%	30.6%
Net Earnings / Revenue	-41.69%	-51.88%	-44.07%
Basic Earnings Per Share
Diluted Earnings Per Share	-$442.1K	-$525.9K	-$364.8K
COMMON SHARES
Basic Shares Outstanding	20.41M shares	20.39M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.90M	$43.10M	$6.600M
YoY Change	175.0%	553.03%
Cash & Equivalents	$31.87M	$43.14M	$6.613M
Short-Term Investments
Other Short-Term Assets	$4.500M	$4.700M	$3.900M
YoY Change	4.65%	20.51%
Inventory	$26.54M	$23.75M	$12.70M
Prepaid Expenses
Receivables	$21.31M	$20.12M	$18.40M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$84.18M	$91.72M	$41.60M
YoY Change	85.82%	120.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.71M	$13.20M	$13.40M
YoY Change	26.58%	-1.48%
Goodwill	$465.0K	$465.0K
YoY Change
Intangibles	$3.081M	$3.248M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$370.0K	$325.0K	$300.0K
YoY Change	-66.36%	8.33%
Total Long-Term Assets	$20.62M	$17.24M	$17.40M
YoY Change	14.58%	-0.92%
TOTAL ASSETS
Total Short-Term Assets	$84.18M	$91.72M	$41.60M
Total Long-Term Assets	$20.62M	$17.24M	$17.40M
Total Assets	$104.8M	$109.0M	$59.00M
YoY Change	65.56%	84.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.531M	$5.583M	$10.60M
YoY Change	13.75%	-47.33%
Accrued Expenses	$8.718M	$6.846M	$4.300M
YoY Change	61.44%	59.21%
Deferred Revenue	$751.0K	$681.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$4.200M
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$400.0K
YoY Change	33.33%
Total Short-Term Liabilities	$21.39M	$16.56M	$20.90M
YoY Change	13.76%	-20.78%
LONG-TERM LIABILITIES
Long-Term Debt	$24.10M	$23.20M	$19.90M
YoY Change	16.43%	16.58%
Other Long-Term Liabilities	$3.415M	$3.378M	$27.00M
YoY Change	-84.12%	-87.49%
Total Long-Term Liabilities	$3.415M	$3.378M	$46.90M
YoY Change	-91.91%	-92.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.39M	$16.56M	$20.90M
Total Long-Term Liabilities	$3.415M	$3.378M	$46.90M
Total Liabilities	$51.01M	$47.93M	$67.80M
YoY Change	-16.37%	-29.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$108.8M	-$99.75M
YoY Change
Common Stock	$146.4M	$146.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.854M	$2.854M
YoY Change
Treasury Stock Shares	408.1K shares	408.1K shares
Shareholders Equity	$53.79M	$61.03M	-$8.760M
YoY Change
Total Liabilities & Shareholders Equity	$104.8M	$109.0M	$59.00M
YoY Change	65.56%	84.67%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$9.040M	-$10.78M	-$6.530M
YoY Change	68.66%	65.07%	30.6%
Depreciation, Depletion And Amortization	$21.00K	$21.00K	$24.00K
YoY Change	-12.5%	-12.5%	-90.4%
Cash From Operating Activities	-$7.060M	-$7.998M	-$5.931M
YoY Change	-21.38%	34.85%	-10.14%
INVESTING ACTIVITIES
Capital Expenditures	-$4.210M	$685.0K	$392.0K
YoY Change	1215.63%	74.74%	-147.23%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$770.0K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$4.210M	-$1.455M	-$414.0K
YoY Change	1215.63%	251.45%	-43.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$1.610M
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.00K	-$16.00K	$1.982M
YoY Change	-100.14%	-100.81%	-86.98%
NET CHANGE
Cash From Operating Activities	-7.060M	-$7.998M	-$5.931M
Cash From Investing Activities	-4.210M	-$1.455M	-$414.0K
Cash From Financing Activities	-20.00K	-$16.00K	$1.982M
Net Change In Cash	-11.29M	-$9.504M	-$4.251M
YoY Change	-324.9%	123.57%	-153.88%
FREE CASH FLOW
Cash From Operating Activities	-$7.060M	-$7.998M	-$5.931M
Capital Expenditures	-$4.210M	$685.0K	$392.0K
Free Cash Flow	-$2.850M	-$8.683M	-$6.323M
YoY Change	-67.09%	37.32%	9.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001688757
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20409223	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2019Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	Establishment Labs Holdings Inc.
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q1	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	743000	USD
CY2019Q1	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	1836000	USD
CY2018Q4	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	0	USD
CY2019Q1	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	386000	USD
CY2018Q4	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	883000	USD
CY2019Q1	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	871000	USD
CY2018Q4	esta	Class Of Warrant Or Right Outstanding Current ClassOfWarrantOrRightOutstandingCurrent	2261000	USD
CY2019Q1	esta	Class Of Warrant Or Right Outstanding Current ClassOfWarrantOrRightOutstandingCurrent	2261000	USD
CY2018Q1	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	500000	USD
CY2019Q1	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	600000	USD
CY2018Q1	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	637000	USD
CY2019Q1	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	633000	USD
CY2019Q1	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	1257000	USD
CY2019Q1	esta	Employee And Non Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Notyet Recognized Periodfor Recognition EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition	P3Y00M01D
CY2018Q4	esta	Line Of Credit Including Interest Payable Current LineOfCreditIncludingInterestPayableCurrent	22322000	USD
CY2019Q1	esta	Line Of Credit Including Interest Payable Current LineOfCreditIncludingInterestPayableCurrent	23190000	USD
CY2018Q1	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	0	USD
CY2018Q1	esta	Noncash Deferred Offering Expense NoncashDeferredOfferingExpense	0	USD
CY2019Q1	esta	Noncash Deferred Offering Expense NoncashDeferredOfferingExpense	337000	USD
CY2018Q1	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	0	USD
CY2019Q1	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	767000	USD
CY2019Q1	esta	Number Of Manufacturing Facilities NumberOfManufacturingFacilities	2	facility
CY2019Q1	esta	Revenue From Contract With Customer Product Return Period RevenueFromContractWithCustomerProductReturnPeriod	P15D
CY2019Q1	esta	Revenue From Contract With Customer Product Shelf Life RevenueFromContractWithCustomerProductShelfLife	P5Y
CY2018Q1	esta	Sharebased Compensation And Issuance Of Stock Or Warrants For Services And Claims SharebasedCompensationAndIssuanceOfStockOrWarrantsForServicesAndClaims	743000	USD
CY2019Q1	esta	Sharebased Compensation And Issuance Of Stock Or Warrants For Services And Claims SharebasedCompensationAndIssuanceOfStockOrWarrantsForServicesAndClaims	1836000	USD
CY2019Q1	esta	Stock Issued During Period Shares Warrant Exercises StockIssuedDuringPeriodSharesWarrantExercises	72570	shares
CY2019Q1	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	56000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6239000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5583000	USD
CY2018Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	0	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17648000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20115000	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3058000	USD
CY2019Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2876000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6125000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6846000	USD
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1300000	USD
CY2019Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1887000	USD
CY2018Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	487000	USD
CY2019Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	299000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5230000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5653000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	449000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	516000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15156000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16837000	USD
CY2019Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	56000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	926000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1022000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	814000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	868000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1516770	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1830721	shares
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018Q4	us-gaap	Assets Assets	116573000	USD
CY2019Q1	us-gaap	Assets Assets	108956000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	99435000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	91716000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	363000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-225000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	914000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	801000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	914000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	801000	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	705000	USD
CY2019Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	357000	USD
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	730000	USD
CY2018Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2019Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	69000	USD
CY2019Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	348000	USD
CY2018Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1400000	USD
CY2019Q1	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1500000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	705000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	36000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	169000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	258000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	76000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	629000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	242000	USD
CY2018Q4	us-gaap	Cash Cash	52639000	USD
CY2019Q1	us-gaap	Cash Cash	43135000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10864000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6613000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52639000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43135000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4251000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9504000	USD
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2019Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3020460	shares
CY2019Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3826869	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20672025	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20803803	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20263955	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20395733	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	145709000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	146285000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6536000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10712000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	908000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	681000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1186000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1167000	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	6901000	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	9526000	USD
CY2018Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1500000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	24000	USD
CY2019Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4800000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	21000	USD
CY2018Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4768000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.53
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	112000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-35000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4200000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1213000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1410000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	583000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	532000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	109000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	345000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	674000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	714000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2957000	USD
CY2018Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	200000	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-400000	USD
CY2018Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-892000	USD
CY2018Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1305000	USD
CY2019Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-32000	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2019Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	465000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	465000	USD
CY2019Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2018	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2019Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	7915000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	11252000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6520000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10735000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44000	USD
CY2018Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	87000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	932000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-619000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5136000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2883000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1229000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1142000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-698000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1744000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-5000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	11000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	621000	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2019Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	161000	USD
CY2019Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4658000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4658000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1647000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	826000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	20496000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	24845000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	23752000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	2242000	USD
CY2018Q1	us-gaap	Interest Paid Net InterestPaidNet	1283000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	1402000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	20252000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3445000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3248000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	2171000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3349000	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2074000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	200000	USD
CY2019Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1244000	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1182000	USD
CY2018Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019Q1	us-gaap	Inventory Write Down InventoryWriteDown	-83000	USD
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000	USD
CY2018Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	200000	USD
CY2019Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	47088000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	47926000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116573000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	108956000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16447000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	16558000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1982000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-16000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-414000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1455000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5931000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7998000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-6530000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-10779000	USD
CY2018Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2019Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1104000	USD
CY2019Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2019Q1	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	10795000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	19640000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2880000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8388000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6941000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	792000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	764000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	765000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	824000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	3137000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	659000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	801000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1273000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	315000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	325000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-6000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	67000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	67000	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4083000	USD
CY2019Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4129000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3551000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3378000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	195000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-304000	USD
CY2018Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	568000	USD
CY2019Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	539000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	2300000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	4700000	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	56000	USD
CY2018Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22000	USD
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	392000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	685000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4303000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4714000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1610000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	436000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	84000	USD
CY2018Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2019Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	58000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18143000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18855000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12913000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13202000	USD
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	35000	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	112000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	64000	USD
CY2019Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	102000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88975000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99754000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2147000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3584000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14816000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20778000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8648000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16056000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	59000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.79
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23778000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	18581000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1486363	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1536422	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.43
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.95
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	10000000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	529614	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	5.19
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.13
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	25.77
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y8M27D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M17D
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5941	shares
CY2018Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1610000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	337000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	743000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1836000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	436000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	84000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-5013000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-8760000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	69485000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	61030000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	479000	USD
CY2019Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	511000	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
CY2018Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1305000	USD
CY2019Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-32000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14662092	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20495671	shares
CY2019Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Other Risks and Uncertainties</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company’s cash is held at one financial institution in the United States. The Company has not experienced any losses on its deposits of cash.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">All of the Company’s revenue has been derived from sales of its products in international markets, principally Europe, Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">March 31, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2018</font><font style="font-family:Arial;font-size:10pt;">, no customers accounted for more than 10% of the Company’s revenue. No customers accounted for more than 10% of the Company’s accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;">March 31, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;color:#231f20;">December 31, 2018</font><font style="font-family:Arial;font-size:10pt;">. Substantially all of the Company’s revenues are derived from the sale of Motiva Implants.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company relies on NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">March 31, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2018</font><font style="font-family:Arial;font-size:10pt;">, the Company had purchases of </font><font style="font-family:Arial;font-size:10pt;">$3.7 million</font><font style="font-family:Arial;font-size:10pt;">, or </font><font style="font-family:Arial;font-size:10pt;">62.9%</font><font style="font-family:Arial;font-size:10pt;"> of total purchases, and </font><font style="font-family:Arial;font-size:10pt;">$2.9 million</font><font style="font-family:Arial;font-size:10pt;">, or </font><font style="font-family:Arial;font-size:10pt;">61.1%</font><font style="font-family:Arial;font-size:10pt;"> of total purchases, respectively, from Nusil. As of </font><font style="font-family:Arial;font-size:10pt;">March 31, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;color:#231f20;">December 31, 2018</font><font style="font-family:Arial;font-size:10pt;">, we had an outstanding balance owed to this vendor of </font><font style="font-family:Arial;font-size:10pt;">$0.6 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$0.8 million</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company’s current and potential future products, uncertainty of market acceptance of the Company’s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.</font></div></div>
CY2019Q1	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Debt and Embedded Derivatives</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Debt with Conversion and Other Options.</font><font style="font-family:Arial;font-size:10pt;"> The Company records, when necessary, discounts to notes payable for the intrinsic value of conversion and other options embedded in debt instruments as a beneficial conversion option based upon the differences between the fair value of the underlying shares at the commitment date of the note transaction and the effective conversion price embedded in the note</font><font style="font-family:Arial;font-size:10pt;"> (see Note 6).</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the consolidated statements of operations</font><font style="font-family:Arial;font-size:10pt;"> (see Note 5).</font></div></div>
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated condensed financial statements and accompanying notes. Significant accounting </font><font style="font-family:Arial;font-size:10pt;">estimates and management judgments reflected in the consolidated condensed financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets’ useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</font><font style="font-family:Arial;font-size:10pt;color:#231f20;"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001688757-19-000025-index-headers.html	Edgar Link	pending
0001688757-19-000025-index.html	Edgar Link	pending
0001688757-19-000025.txt	Edgar Link	pending
0001688757-19-000025-xbrl.zip	Edgar Link	pending
esta-20190331.xml	Edgar Link	completed
esta-20190331.xsd	Edgar Link	pending
esta-20190331_cal.xml	Edgar Link	unprocessable
esta-20190331_def.xml	Edgar Link	unprocessable
esta-20190331_lab.xml	Edgar Link	unprocessable
esta-20190331_pre.xml	Edgar Link	unprocessable
establishmentlabs10q_2019q1.htm	Edgar Link	pending
exhibit311q12019.htm	Edgar Link	pending
exhibit312q12019.htm	Edgar Link	pending
exhibit321q12019.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2019 Q2 Form 10-Q Financial Statement

#000168875719000025 Filed on May 15, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2019 Q2 Form 10-Q Financial Statement

#000168875719000025 Filed on May 15, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta